Glucagon-like peptide-1 receptor agonists (GLP-1RAs), a category of antidiabetic medications such as semaglutide and liraglutide, have dramatically improved outcomes in the treatment of T2D and obesity, significantly reducing complications from their metabolic consequences including cardiovascular and chronic kidney disease [20, 21]
A head-to-head multi-parametric high content analysis of a series of medium chain fatty acid intestinal permeation enhancers in Caco-2 cells
Liposomal Glutathione for Skin Health and Brightening Liposomal glutathione is best known for its potential skin-brightening and anti-ageing effects
That means residents can depend on us not only for immediate support but also for guidance that helps sustain progress long after treatment

Seek advice from a GP if you experience: Unintentional weight loss of 5% or more of your body weight over 6 to 12 months, or more rapid unexplained loss, particularly if accompanied by other symptoms such as fatigue, night sweats, persistent pain, or changes in bowel habit these may require urgent assessment in line with NICE guidance on suspected cancer (NG12) Difficulty losing weight despite sustained dietary changes and increased activity, particularly if accompanied by symptoms such as fatigue, cold intolerance, or irregular periods, which may suggest an underlying condition such as hypothyroidism or PCOS A BMI above 40 kg/m, or above 35 kg/m with significant obesity-related comorbidities such as type 2 diabetes or hypertension, where referral to a specialist Tier 3 or Tier 4 (bariatric surgery) service may be appropriate lower BMI thresholds (typically 2

281 PEGylated lipids are another crucial component of LNPs that significantly influence their size, stability, and in vivo distribution